Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1

International Journal of Cancer

Volumn 125, Issue 11, 2009, Pages 2511-2519

  Liu, Funan ^a   Li, Xiaodong ^a   Wang, Chunyu ^a   Cai, Xinze ^a   Du, Zhongmin ^a   Xu, Huimian ^a   Li, Feng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Cyclin b1; Gastric cancer; NF B; p21 activated kinase 1

Indexed keywords

CYCLIN B1; MESSENGER RNA; P21 ACTIVATED KINASE 1; CYCLIN B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; P21 ACTIVATED KINASE; PAK1 PROTEIN, HUMAN; PAK1 PROTEIN, MOUSE; SMALL INTERFERING RNA;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; WESTERN BLOTTING; ANIMAL; CELL CYCLE; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LYMPH NODE METASTASIS; METABOLISM; NORTHERN BLOTTING; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CYCLIN B; DOWN-REGULATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MICE; MICE, NUDE; NF-KAPPA B; P21-ACTIVATED KINASES; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 70350714440     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24588     Document Type: Article

References (30)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006;12:354-362
2. Ohgaki H, Matsukura N. Stomach cancer. In: Stewart BW, Kleihues P, eds. World cancer report. Lyon: IARC Press, 2003.197 p.
3. Stadtlander CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999;20:2195-2208
4. El-Rifai W, Powell SM. Molecular biology of gastric cancer. Semin Radiat Oncol 2002;12:128-140
5. Kumar R, Vadlamudi RK. Emerging functions of p21-activated kinases in human cancer cells. J Cell Physiol 2002;193:133-144
6. Schurmann A, Mooney AF, Sanders LC, Sells MA, Wang HG, Reed JC, Bokoch GM. P21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol Cell Biol 2000;20:453-461 (Pubitemid 30023086)
7. Vadlamudi RK, Adam L, Wang RA, Mandal M, Nguyen D, Sahin A, Chernoff J, Hung MC, Kumar R. Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 2000;275:36238-36244 (Pubitemid 30841175)
8. Rider L, Shatrova A, Feener EP, Webb L, Diakonova M. JAK2 tyrosine kinase phosphorylates PAK1 and regulates PAK1 activity and functions. J Biol Chem 2007;282:30985-30996 (Pubitemid 350035237)
9. King CC, Gardiner EM, Zenke FT, Bohl BP, Newton AC, Hemmings BA, Bokoch GM. P21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositidedependent kinase-1 (PDK1). J Biol Chem 2000;275:41201-41209
10. Howe AK, Juliano RL. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nature Cell Biol 2000;2:593-600. (Pubitemid 30742832)
11. Chong C, Tan L, Lim L, Manser E. The mechanism of Pak activation. Autophosphorylation events in both regulatory and kinase domains control activity. J Biol Chem 2001;276:17347-17353 (Pubitemid 37411545)
12. Vadlamudi RK, Adam L, Wang RA, Mandal M, Nguyen D, Sahin A, Chernoff J, Hung MC, Kumar R. Regulatable expression of p21-activated kinase-1 promotes anchorage- independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 2000;275:36238-36244
13. Carter JH, Douglass LE, Deddens JA, Colligan BM, Bhatt TR, Pemberton JO, Konicek S, Hom J, Marshall M, Graff JR. Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res 2004;10:3448-3456 (Pubitemid 38685452)
14. Schraml P, Schwerdtfeger G, Burkhalter F, Raggi A, Schmidt D, Ruffalo T, King W, Wilber K, Mihatsch MJ, Moch H. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 2003;163:985-992 (Pubitemid 37040134)
15. O'sullivan GC, Tangney M, Casey G, Ambrose M, Houston A, Barry OP. Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma. Int J Cancer 2007;121:1930-1940
16. Wang RA, Mazumdar A, Vadlamudi RK, Kumar R. P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-a and promotes hyperplasia in mammary epithelium. EMBO J 2002;21:5437-5447 (Pubitemid 35231023)
17. Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer 2006;6:459-471
18. Vadlamudi RK, Li F, Adam L, Nguyen D, Ohta Y, Stossel TP, Kumar R. Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol 2002;4:681-690 (Pubitemid 34993704)
19. Leung TW, Lin SS, Tsang AC, Tong CS, Ching JC, Leung WY, Gimlich R, Wong GG, Yao KM. Over-expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett 2001;507:59-66. (Pubitemid 33000299)
20. Algarté M, Nguyen H, Heylbroeck C, Lin R, Hiscott J. IκB-mediated inhibition of virus-induced b interferon transcription. J Virol 1999;73:2694-2702 (Pubitemid 29135654)
21. Ching YP, Leong VY, Lee MF, Xu HT, Jin DY, Ng IO. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation. Cancer Res 2007;67:3601-3608
22. Li F, Adam L, Vadlamudi RK, Zhou H, Sen S, Chernoff J, Mandal M, Kumar R. p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO Rep 2002;3:767-773 (Pubitemid 34966016)
23. Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK, Kumar R. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 2004;279:1422-1428 (Pubitemid 38082670)
24. Cude K, Wang Y, Choi HJ, Hsuan SL, Zhang H, Wang CY, Xia Z. Regulation of the G2-M cell cycle progression by the ERK5-NFκB signaling pathway. J Cell Biol 2007;177:253-264 (Pubitemid 46658637)
25. Curry CL, Reed LL, Broude E, Golde TE, Miele L, Foreman KE. Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-κB signaling. Mol Cancer Ther 2007;6:1983-1992 (Pubitemid 47052488)
26. Dadke D, Fryer BH, Golemis EA, Field J. Activation of p21-activated kinase 1-nuclear factor κB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation. Cancer Res 2003;63:8837-8847 (Pubitemid 38064063)
27. Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R, Cobb MH. Stimulation of. NFκB activity by multiple signaling pathways requires PAK1. J Biol Chem 2000;275:19693-19699 (Pubitemid 30441565)
28. Foryst-Ludwig A, Naumann M. p21-activated kinase 1 activates the nuclear factor κB (NF-κB)-inducing kinase-Iκ B kinases NF-κB pathway and proinflammatory cytokines in Helicobacter pylori infection. J Biol Chem 2000;275:39779-39785 (Pubitemid 32059009)
29. Zhao ZS, Lim JP, Ng YW, Lim L, Manser E. The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A. Mol Cell 2005;20:237-249 (Pubitemid 41484169)
30. Maroto B, Ye MB, von Lohneysen K, Schnelzer A, Knaus UG. P21-activated kinase is required for mitotic progression and regulates Plk1. Oncogene 2008;27:4900-4908